Hello, Fool! | Login | Signup | My Fool
Oct 11, 2008 11:01 AM ET | Feedback | Site Changes | Help
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
View Ticker Page (BIIB)
Results 31 - 40 of 78 : 12345Next »
Recs
addaam78 (97.20) Submitted: 8/08/08 4:19 PM : Start Price: $50.35 BIIB Score: 16.62
Great, innovative company with earnings and revenue growth. It markets 4 drugs at the moment and has lost some 20% in a few days due to the Tysabri scare.It is a possible takeover target and if the drug is not pulled out of the market it ...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
edwardthefool (< 20) Submitted: 8/08/08 3:26 PM : Start Price: $50.10 BIIB Score: 17.11
Another buying opportunity of significance, with ignorant press reports in M* videos, missinformation abounds. Buy now! MS drug takers have been warned of the risk, and only two in two years are affected. FDA rules have been adhered to by BIIB and...
Dzerzhinsky (< 20) Submitted: 8/06/08 4:30 PM : Start Price: $50.13 BIIB Score: 16.18
Viral-reactivation induced PML (progressive multifocal leukoencephalopathy) is a dangerous disease now associated with Tsybari treatment, and the recent report of two more patient deaths has led to a precipitous sell-off. However, one hopes that with...
mjan706 (< 20) Submitted: 9/22/08 1:39 AM : Start Price: $50.13 BIIB Score: 14.31
An Icahn portfolio stock.
dcamsterdam (62.98) Submitted: 10/01/08 2:08 PM : Start Price: $48.55 BIIB Score: 11.57
Democrats will spend more on health care, I like current price
cayamax (< 20) Submitted: 8/01/08 11:33 AM : Start Price: $52.36 BIIB Score: 11.68
Looks like stockholders are over reacting.
oldnbroke441 (91.29) Submitted: 10/03/08 11:59 PM : Start Price: $50.16 BIIB Score: 2.69
20 day breakout
InvestRx (95.91) Submitted: 10/07/08 4:47 PM : Start Price: $49.57 BIIB Score: -4.61
The FDA has published a table with the names of products and potential signals of serious risks and/or new safety information identified for these products during 1Q08 in the AERS database. The FDA notes that patients should not stop taking these med...
supercoffee (96.15) Submitted: 7/31/08 5:52 PM : Start Price: $51.66 BIIB Score: -13.07
going low
icanpickm (98.46) Submitted: 7/23/08 11:31 AM : Start Price: $71.94 BIIB Score: -9.37
great quarter, low pe, maybe ready for someone to buy them.
Terms & Conditions
RSS Headlines
Fool UK